Dr. Ryan Uitti, MD

• Neurology

*Healthgrades does not verify qualifications for medical specialties. Please verify your provider's specialty and qualifications directly with your provider and applicable medical board.

• University Bc

  Fellowship Hospital

• Mayo Grad School Of Medicine|university Saskatchewan - University Hospital

  Residency Hospital

• University Hospital

  Internship Hospital

• World Federation of Neurology Research, Executive Committee

• Research Operations Management Team - Division of Research Service - Department of Administration, Member

• World Federation of Neurology, Member

• Education Committee - Department of Neurology, Member

• Committee on Parkinsons Disease and Related Disorders - World Federation of Neurology Research, Member

• Research Committee - Department of Neurology, Member

• Movement Disorder Section - American Academy of Neurology, Member

• Division of Movement Disorders - Department of Neurology, Member

• Neurology Residency Education Committee - Department of Neurology, Member

• Practice Analytics Oversight Group, Member

• Neuroscience Finance Committee - Mayo Clinic Florida Committees, Member

• 15th International Congress on Parkinsons Disease Beijing China - World Federation of Neurology Research, Lead Organizer

• Information and Referral Center - American Parkinsons Disease Association Inc., Member

• Genetic architecture of Parkinson's disease subtypes - Review of the literature, 2022-10-20

• ABI3andPLCG2missense variants as risk factors for neurodegenerative diseases in Caucasians and African Americans, 2018-10-11

• Latent trait modeling of tau neuropathology in progressive supranuclear palsy, 2021-02-26

• Association of Parkinson disease age of onset withDRD2,DRD3andGRIN2Bpolymorphisms, 2015-11-25

• DNAJC13 p.Asn855Ser mutation screening in Parkinson's disease and pathologically confirmed Lewy body disease patients, 2015-05-20

• High-throughput mutational analysis ofTOR1Ain primary dystonia, 2009-03-11

• DRD3Ser9Gly andHS1BP3Ala265Gly are not associated with Parkinson Disease, 2009-06-12

• Angiogenin variation and Parkinson's disease, 2012-03-23

• Update on novel familial forms of Parkinson's disease and multiple system atrophy, 2014-10-07

• Genetic variation of the retromer subunits VPS26A/B-VPS29 in Parkinson's disease, 2014-03-05

• Cancer in Parkinson's disease, 2016-06-20

• LINGO1andLINGO2variants are associated with essential tremor and Parkinson disease, 2010-04-06

• Population-specific frequencies forLRRK2susceptibility variants in the Genetic Epidemiology Of Parkinson's Disease (GEO-PD) consortium, 2013-08-02

• Urine levels of the polyglutamine ataxin-3 protein are elevated in patients with spinocerebellar ataxia type 3, 2021-07-17

• Three sib-pairs of autopsy-confirmed progressive supranuclear palsy, 2014-11-15

• Mitochondrial genomic variation in dementia with Lewy bodies: association with disease risk and neuropathological measures, 2022-07-14

• RAB39Bgene mutations are not a common cause of Parkinson's disease or dementia with Lewy bodies, 2016-03-24

• Novel mutation inMAPTexon 13 (p.N410H) causes corticobasal degeneration, 2013-11-19

• Association ofABI3andPLCG2missense variants with disease risk and neuropathology in Lewy body disease and progressive supranuclear palsy, 2020-10-22

• Genetic variation ofOmi/HtrA2and Parkinson's disease, 2008-09-14

• Exonic Re-Sequencing of the Chromosome 2q24.3 Parkinson's Disease Locus, 2015-06-19

• FGF20and Parkinson's disease: No evidence of association or pathogenicity via a-synuclein expression, 2009-02-15

• Whole-exome sequencing for variant discovery in blepharospasm, 2018-05-16

• MAPTsubhaplotypes in corticobasal degeneration: assessing associations with disease risk, severity of tau pathology, and clinical features, 2020-12-07

• A Consensus Set of Outcomes for Parkinson's Disease from the International Consortium for Health Outcomes Measurement, 2017-11-07

• Multiple system atrophy and apolipoprotein E, 2018-02-14

• Investigating the role ofFUSexonic variants in Essential Tremor, 2013-04-16

• TREM2 in neurodegeneration: evidence for association of the p.R47H variant with frontotemporal dementia and Parkinson's disease, 2013-06-21

• InvestigatingFUSvariation in Parkinson's disease, 2016-01-15

• LINGO1rs9652490 is associated with Essential Tremor and Parkinson Disease, 2009-08-31

• Daytime sleepiness in dementia with Lewy bodies is associated with neuronal depletion of the nucleus basalis of Meynert, 2018-02-03

• Fine-mapping of the non-coding variation driving the CaucasianLRRK2GWAS signal in Parkinson's disease, 2021-01-11

• Parkinsonian features in hereditary diffuse leukoencephalopathy with spheroids (HDLS) andCSF1Rmutations, 2013-06-17

• Loss of ability to work and ability to live independently in Parkinson's Disease, 2011-10-04

• Human leukocyte antigen variation and Parkinson's disease, 2011-04-11

• Cognitive impairment in progressive supranuclear palsy is associated with tau burden, 2017-10-30

• DJ-1 and aSYN in LRRK2 CSF do not correlate with striatal dopaminergic function, 2011-10-21

• Analysis of Nuclear Export Sequence Regions of FUS-Related RNA-Binding Proteins in Essential Tremor, 2014-11-06

• MAPThaplotype H1G is associated with increased risk of dementia with Lewy bodies, 2016-06-07

• Phosphorylated a-synuclein in Parkinson's disease: correlation depends on disease severity, 2015-01-31

• Cognitive Profile ofLRRK2-related Parkinson's Disease, 2015-02-04

• Serotonin transporter binding and motor onset of Parkinson's disease in asymptomaticLRRK2mutation carriers: a cross-sectional study, 2017-03-20

• Frequency of spinocerebellar ataxia mutations in patients with multiple system atrophy, 2021-01-27

• Anatomy of Disturbed Sleep in Pallido-Ponto-Nigral Degeneration, 2014-01-21

• InvestigatingELOVL7coding variants in Multiple System Atrophy, 2021-02-15

• The limbic and neocortical contribution of a-synuclein, tau and ß-amyloid to disease duration in dementia with Lewy bodies, 2017-10-31

• Evaluation of the Role ofSNCAVariants in Survival without Neurological Disease, 2012-08-13

• Independent and joint effects of theMAPTandSNCAgenes in Parkinson's disease, 2011-03-09

• Common Variants Near ZIC1 and ZIC4 in Autopsy-Confirmed Multiple System Atrophy, 2022-08-23

• The c.-237_236GA>TTTHAP1Sequence Variant Does Not Increase Risk for Primary Dystonia, 2011-03-02

• Genome-wide analyses as part of the international FTLD-TDP whole genome sequencing consortium reveals novel disease risk factors and increases support for immune dysfunction in FTLD, 2019-02-09

• Analysis of theC9orf72repeat in Parkinson's disease, essential tremor and restless legs syndrome, 2012-10-18

• The protective effect of LRRK2 p.R1398H on risk of Parkinson's disease is independent ofMAPTandSNCAvariants, 2013-08-17

• Occurrence of Crohn's disease with Parkinson's disease, 2017-02-10

• Neuropathologic basis of frontotemporal dementia in progressive supranuclear palsy Sakae et al, 2019-08-21

• TARDBPmutations in Parkinson's disease, 2012-12-08

• Validation of the Neuropathologic Criteria of the Third Consortium for Dementia with Lewy Bodies for Prospectively Diagnosed Cases, 2009-07-15

• A clinicopathologic subtype of Alzheimer's disease presenting as corticobasal syndrome, 2019-08-06

• Correction to: A nonsynonymous mutation inPLCG2reduces the risk of Alzheimer's disease, dementia with Lewy bodies and frontotemporal dementia, and increases the likelihood of longevity, 2020-01-18

• Length of normal alleles ofC9ORF72GGGGCC repeat do not influence disease phenotype, 2012-07-26

• Underlying pathology identified after 20 years of disease course in two cases of slowly progressive frontotemporal dementia syndromes, 2021-04-27

• A nonsynonymous mutation inPLCG2reduces the risk of Alzheimer's disease, dementia with Lewy bodies and frontotemporal dementia, and increases the likelihood of longevity, 2019-05-26

• SLC1A2rs3764087 does not associate with essential tremor, 2013-10-16

• Identification of common variants influencing risk of the tauopathy Progressive Supranuclear Palsy, 2011-06-19

• Genome-wide association study of corticobasal degeneration identifies risk variants shared with progressive supranuclear palsy, 2015-06-16

• Pathogenicity of exonic indels infused in sarcomain amyotrophic lateral sclerosis, 2010-11-12

• Association of Mitochondrial Genomic Background with Risk of Multiple System Atrophy, 2020-10-29

• MAPThaplotype diversity in multiple system atrophy, 2016-06-16

• Associations of mitochondrial genomic variation with corticobasal degeneration, progressive supranuclear palsy, and neuropathological tau measures, 2020-09-17

• Tremor in progressive supranuclear palsy, 2016-03-22

• Cerebellar ataxia in progressive supranuclear palsy: an autopsy study of PSP-C, 2016-02-03

• Distribution and characteristics of TDP-43 pathology in progressive supranuclear palsy, 2016-12-23

• Phactr2and Parkinson's disease, 2009-02-10

• Replication of progressive supranuclear palsy genome-wide association study identifiesSLCO1A2andDUSP10as new susceptibility loci, 2018-07-09

• A curious case of DBS radiofrequency programmer interference, 2019-02-01

• Association ofMAPTsubhaplotypes with clinical and demographic features in Parkinson's disease A.B. Deutschlanderet al., 2020-08-07

• Glutathione S-transferase omega genes in Alzheimer and Parkinson disease risk, age-at-diagnosis and brain gene expression: an association study with mechanistic implications, 2012-04-11

• Screening non-MAPTgenes of the Chr17q21 H1 haplotype in Parkinson's disease, 2020-08-01

• Cancer in pathologically confirmed multiple system atrophy, 2023-05-13

• Toward allele-specific targeting therapy and pharmacodynamic marker for spinocerebellar ataxia type 3, 2020-10-21

• Deep brain stimulation for levodopa-refractory benign tremulous parkinsonism, 2016-06-24

• LRRK2variation and dementia with Lewy bodies, 2016-07-29

• Profile of cognitive impairment and underlying pathology in multiple system atrophy, 2016-11-15

• Biomarkers in Parkinson's disease: Advances and strategies, 2015-09-30

• Corticobasal degeneration with TDP-43 pathology presenting with progressive supranuclear palsy syndrome: A distinct clinicopathologic subtype, 2018-06-20